<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(9)</volume><submitter>Obermannova R</submitter><journal>Annals of oncology : official journal of the European Society for Medical Oncology</journal><pagination>S1131-S1131</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8454423</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity</pubmed_title><pmcid>PMC8454423</pmcid><pubmed_authors>Mlnarikova M</pubmed_authors><pubmed_authors>Mayer J</pubmed_authors><pubmed_authors>Nevrlka J</pubmed_authors><pubmed_authors>Demlova R</pubmed_authors><pubmed_authors>Valik D</pubmed_authors><pubmed_authors>Zdrazilova-Dubska L</pubmed_authors><pubmed_authors>Weinbergerova B</pubmed_authors><pubmed_authors>Okrouhlicova D</pubmed_authors><pubmed_authors>Selingerova I</pubmed_authors><pubmed_authors>Obermannova R</pubmed_authors><pubmed_authors>Doubek M</pubmed_authors><pubmed_authors>Cermakova Z</pubmed_authors><pubmed_authors>Pilatova K</pubmed_authors><pubmed_authors>Lejdarova H</pubmed_authors><pubmed_authors>Kiss I</pubmed_authors></additional><is_claimable>false</is_claimable><name>1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-19T10:33:55.004Z</modification><creation>2022-02-11T11:17:11.47Z</creation></dates><accession>S-EPMC8454423</accession><cross_references/></HashMap>